Try our Advanced Search for more refined results

J&J Hit With $1.75M Verdict In 4th Philly Risperdal Case

By Matt Fair ( November 9, 2015, 3:41 PM EST) -- A Johnson & Johnson unit was slapped with a $1.75 million verdict in Pennsylvania state court on Monday in a fourth case alleging the company failed to properly disclose the risks of abnormal breast growth in adolescent boys using the antipsychotic drug Risperdal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!